Citizens Financial Group »

Arcutis Biotherapeutics shares owned by Citizens Financial Group

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Citizens Financial Group from 13F filings

Historical chart of Citizens Financial Group investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by Citizens Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by Citizens Financial Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $922k 35k 26.22

More positions owned by Citizens Financial Group

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core S&p Mcp Etf (IJH)
Microsoft Corporation (MSFT)
Ishares Tr Core Msci Eafe (IEFA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Vanguard Tax Managed Intl Ftse Dev Mkt Etf (VEA)
Ishares Core Msci Emkt (IEMG)
Vanguard Index Fds Value Etf (VTV)
Broadcom (AVGO)
Ishares Tr Russell 2000 Etf (IWM)

View all positions for Citizens Financial Group

Top funds holding Arcutis Biotherapeutics

Suvretta Capital Management
BlackRock
Frazier Life Sciences Management
Rubric Capital Management
Polar Capital Holdings
State Street Corporation
Vanguard Capital Management
Jennison Associates
Morgan Stanley
D. E. Shaw & Co
UBS Group
Bank of America Corporation
Geode Capital Management
Vanguard Portfolio Management
OrbiMed Advisors

View all funds holding Arcutis Biotherapeutics